GRANULES INDIA
Back to Balance Sheet
|
GRANULES INDIA Last 5 Year Total Non-Current Liabilities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Total Non-Current Liabilities | ₹479 Cr | ₹466 Cr | ₹176 Cr | ₹255 Cr | ₹283 Cr |
What is the latest Total Non-Current Liabilities ratio of GRANULES INDIA ?
| Year | Total Non-Current Liabilities |
|---|---|
| Mar2026 | ₹479 Cr |
| Mar2025 | ₹466 Cr |
| Mar2024 | ₹176 Cr |
| Mar2023 | ₹255 Cr |
| Mar2022 | ₹283 Cr |
How is Total Non-Current Liabilities of GRANULES INDIA Trending?
| Years | Total Non-Current Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹479 Cr | 2.81 | |
| Mar2025 | ₹466 Cr | 164.71 | |
| Mar2024 | ₹176 Cr | -30.89 | |
| Mar2023 | ₹255 Cr | -9.94 | |
| Mar2022 | ₹283 Cr | - | |
Compare Total Non-Current Liabilities of peers of GRANULES INDIA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| GRANULES INDIA | ₹23,870.0 Cr | -3.8% | 4.4% | 62.8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹440,398.0 Cr | -0.4% | -3.3% | 15.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹248,664.0 Cr | 0.4% | 9.9% | 55.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹182,738.0 Cr | -3.4% | -4.2% | 37.1% | Stock Analytics | |
| CIPLA | ₹110,794.0 Cr | 0.5% | -3.2% | -12.8% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹97,749.4 Cr | 0.9% | 0% | -11% | Stock Analytics | |
GRANULES INDIA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| GRANULES INDIA | -3.8% |
4.4% |
62.8% |
| SENSEX | -0.8% |
-3.8% |
-8.9% |
You may also like the below Video Courses